You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Mallinckrodt
AstraZeneca
McKinsey
Colorcon

Last Updated: April 8, 2020

DrugPatentWatch Database Preview

Felbamate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

Drug Prices for felbamate

See drug prices for felbamate

Recent Clinical Trials for felbamate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Instituto Nacional de Salud Publica, MexicoPhase 3
Laboratorios Grossman, S.A.Phase 3
Federal University of São PauloPhase 4

See all felbamate clinical trials

Pharmacology for felbamate
Synonyms for felbamate
(3-aminocarbonyloxy-2-phenyl-propyl) carbamate
(3-carbamoyloxy-1,1,3,3-tetradeuterio-2-phenylpropyl) carbamate
(3-carbamoyloxy-2-phenylpropyl) carbamate
1,3-Propanediol, 2-phenyl-, dicarbamate
2-?methyl-?4-?(4-?methyl-?1-?piperazinyl)-?10H-?thieno[2,?3-?b][1,?5]benzodiazepine
2-Phenyl-1,3-propanediol dicarbamate
2-Phenyl-1,3-propanedioldicarbamate
2-Phenylpropane-1,3-diyl dicarbamate
25451-15-4
3-(carbamoyloxy)-2-phenylpropyl carbamate
4-06-00-05993 (Beilstein Handbook Reference)
451F154
A817858
AB0011540
AB00382985_19
AB00382985-18
AB1008593
AC-8197
ACN-054465
ADD 03055
ADD-03055
AKOS015895100
ANW-65602
AOB5042
API0002680
AX8130043
BCP27941
BDBM50088430
BIDD:GT0463
Biomol-NT_000203
BN0583
BPBio1_001258
BRD-K99107520-001-01-9
BRD-K99107520-001-09-2
BRD-K99107520-001-18-3
BRN 3345236
C-14192
C07501
carbamic acid (3-carbamoyloxy-2-phenylpropyl) ester
carbamic acid 2-phenyltrimethylene ester
Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester
Carbamic acid, 2-phenyltrimethylene ester
CAS-25451-15-4
CC-28364
CCG-204614
CHEBI:4995
CHEMBL1094
CS-2068
D00536
DB-046702
DB00949
DSSTox_CID_3041
DSSTox_GSID_23041
DSSTox_RID_76847
DTXSID9023041
EINECS 247-001-4
EN300-119542
EU-0100524
EX-A591
F 0778
Felbamate (USAN/INN)
Felbamate [USAN:INN]
Felbamate, United States Pharmacopeia (USP) Reference Standard
Felbamato
Felbamato [Spanish]
Felbamatum
Felbamatum [Latin]
Felbamyl
Felbatol
Felbatol (TN)
FT-0630517
GTPL5473
HMS2093P19
HMS2234H06
HMS3261J09
HMS3266L12
HMS3370I06
HMS3411P21
HMS3657I11
HMS3675P21
HMS3715D20
HSDB 7525
HY-B0184
J90036
K-6677
KS-00001F6O
KS-1171
Lopac-F-0778
Lopac0_000524
LP00524
LS-120706
MCULE-2661497722
MFCD00865296
MLS000028465
MLS001077299
NCGC00015429-01
NCGC00015429-02
NCGC00015429-03
NCGC00015429-04
NCGC00015429-05
NCGC00015429-06
NCGC00015429-07
NCGC00015429-08
NCGC00015429-09
NCGC00015429-10
NCGC00015429-11
NCGC00015429-14
NCGC00023092-02
NCGC00023092-04
NCGC00023092-05
NCGC00023092-06
NCGC00255275-01
NCGC00261209-01
NSC-759866
NSC759866
Opera_ID_1738
Pharmakon1600-01505600
Prestwick0_000919
Q-100326
Q421301
s1330
SBI-0050507.P002
SC-46002
SCHEMBL34947
SMR000058448
SR-01000000089
SR-01000000089-2
SR-01000000089-4
SR-01000000089-7
SW197633-2
Taloxa
TC-154347
Tocris-0869
Tox21_110145
Tox21_110145_1
Tox21_302368
Tox21_500524
UNII-X72RBB02N8
W 554
W-554
WKGXYQFOCVYPAC-UHFFFAOYSA-N
X72RBB02N8
Z1541638522
ZINC1530803

US Patents and Regulatory Information for felbamate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms FELBAMATE felbamate TABLET;ORAL 201680-001 Sep 13, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-001 Jul 29, 1993 AB RX Yes No   Start Trial   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate SUSPENSION;ORAL 020189-003 Jul 29, 1993 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Cadila FELBAMATE felbamate TABLET;ORAL 208970-002 May 30, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for felbamate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-001 Jul 29, 1993   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate SUSPENSION;ORAL 020189-003 Jul 29, 1993   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate SUSPENSION;ORAL 020189-003 Jul 29, 1993   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Mallinckrodt
AstraZeneca
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.